Nothing Special   »   [go: up one dir, main page]

EE200200113A - Püruvaatdehüdrogenaasi aktiivsust tõstvad asendatud N-fenüül-2-hüdroksü-2-metüül-3,3,3-trifluoropropaanamiidi derivaadid - Google Patents

Püruvaatdehüdrogenaasi aktiivsust tõstvad asendatud N-fenüül-2-hüdroksü-2-metüül-3,3,3-trifluoropropaanamiidi derivaadid

Info

Publication number
EE200200113A
EE200200113A EEP200200113A EEP200200113A EE200200113A EE 200200113 A EE200200113 A EE 200200113A EE P200200113 A EEP200200113 A EE P200200113A EE P200200113 A EEP200200113 A EE P200200113A EE 200200113 A EE200200113 A EE 200200113A
Authority
EE
Estonia
Prior art keywords
hydroxy
phenyl
substituted
methyl
dehydrogenase activity
Prior art date
Application number
EEP200200113A
Other languages
English (en)
Inventor
John Butlin Roger
Elizabeth Pease Janet
Howard Block Michael
Nowak Thorsten
Nicholas Burrows Jeremy
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9920814.2A external-priority patent/GB9920814D0/en
Priority claimed from GB0006641A external-priority patent/GB0006641D0/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of EE200200113A publication Critical patent/EE200200113A/et
Publication of EE05080B1 publication Critical patent/EE05080B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
    • C07C317/38—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atom of at least one amino group being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfones
    • C07C317/42—Y being a hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/48—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C317/50—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/64—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
    • C07C323/65—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfone or sulfoxide groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Pyrrole Compounds (AREA)
EEP200200113A 1999-09-04 2000-08-30 Pruvaatdehdrogenaasi aktiivsust t?stvad asendatud N-fenl-2-hdroks-2-metl-3,3,3-trifluoropropaanamiidi derivaadid EE05080B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9920814.2A GB9920814D0 (en) 1999-09-04 1999-09-04 Chemical compounds
GB0006641A GB0006641D0 (en) 2000-03-21 2000-03-21 Chemical compounds
PCT/GB2000/003314 WO2001017956A1 (en) 1999-09-04 2000-08-30 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity

Publications (2)

Publication Number Publication Date
EE200200113A true EE200200113A (et) 2003-06-16
EE05080B1 EE05080B1 (et) 2008-10-15

Family

ID=26243905

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200113A EE05080B1 (et) 1999-09-04 2000-08-30 Pruvaatdehdrogenaasi aktiivsust t?stvad asendatud N-fenl-2-hdroks-2-metl-3,3,3-trifluoropropaanamiidi derivaadid

Country Status (32)

Country Link
US (1) US6689909B1 (et)
EP (1) EP1214296B1 (et)
JP (1) JP2003508515A (et)
KR (1) KR100692232B1 (et)
CN (1) CN1235877C (et)
AR (1) AR035163A1 (et)
AT (1) ATE262507T1 (et)
AU (1) AU760061B2 (et)
BG (1) BG65099B1 (et)
BR (1) BR0013694A (et)
CA (1) CA2381581A1 (et)
CO (1) CO5190690A1 (et)
CZ (1) CZ2002773A3 (et)
DE (1) DE60009319T2 (et)
DK (1) DK1214296T3 (et)
EE (1) EE05080B1 (et)
ES (1) ES2216940T3 (et)
HK (1) HK1045496B (et)
HU (1) HUP0202725A3 (et)
IL (2) IL148111A0 (et)
IS (1) IS2069B (et)
MX (1) MXPA02002319A (et)
MY (1) MY127036A (et)
NO (1) NO20021040L (et)
NZ (1) NZ517147A (et)
PL (1) PL353887A1 (et)
PT (1) PT1214296E (et)
RU (1) RU2255085C2 (et)
SK (1) SK286774B6 (et)
TR (1) TR200200550T2 (et)
TW (1) TW577867B (et)
WO (1) WO2001017956A1 (et)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2307528T3 (es) 1999-09-04 2008-12-01 Astrazeneca Ab Amidas como inhibidores para la piruvato deshidrogenasa.
GB0012012D0 (en) * 2000-05-19 2000-07-05 Astrazeneca Ab Chemical compound
GB0120471D0 (en) * 2001-08-23 2001-10-17 Astrazeneca Ab Chemical compounds
US7399775B2 (en) * 2001-12-27 2008-07-15 Daiichi Pharmaceutical Co., Ltd. β-amyloid protein production/secretion inhibitor
US9388164B2 (en) 2011-05-03 2016-07-12 Agios Pharmaceuticals, Inc Methods of using pyruvate kinase activators
CN104822672B (zh) 2012-11-08 2018-08-28 安吉奥斯医药品有限公司 治疗性化合物和组合物以及其作为pkm2调节剂的用途
WO2014139144A1 (en) 2013-03-15 2014-09-18 Agios Pharmaceuticals, Inc. Therapeutic compounds and compositions
WO2019035865A1 (en) 2017-08-15 2019-02-21 Agios Pharmaceuticals Inc. MODULATORS OF PYRUVATE KINASE AND THEIR USE
CN109096186B (zh) * 2018-09-29 2020-08-04 中南大学 一种2-芳磺酰基喹啉衍生物的合成方法
AR126913A1 (es) * 2021-09-01 2023-11-29 Japan Tobacco Inc Compuesto tricíclico que contiene nitrógeno y su uso farmacéutico

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2862100D1 (en) 1977-10-12 1983-01-05 Ici Plc Acylanilides, process for their manufacture and pharmaceutical and veterinary compositions containing them
US4191775A (en) 1977-12-15 1980-03-04 Imperial Chemical Industries Limited Amide derivatives
NZ197008A (en) 1980-05-22 1984-10-19 Ici Ltd Acylanilide derivatives and pharmaceutical compositions
AU8961382A (en) 1981-11-06 1983-05-12 Imperial Chemical Industries Plc Amide derivatives
US4537618A (en) 1982-05-26 1985-08-27 Ciba Geigy Corporation N-phenylsulfonyl-N'-pyrimidinylureas
EP0100172B1 (en) 1982-07-23 1987-08-12 Imperial Chemical Industries Plc Amide derivatives
GB8617653D0 (en) 1986-07-18 1986-08-28 Ici Plc Amide derivatives
GB8617652D0 (en) 1986-07-18 1986-08-28 Ici Plc Acylanilide derivatives
GB9214120D0 (en) * 1991-07-25 1992-08-12 Ici Plc Therapeutic amides
EP0539329A1 (de) 1991-10-25 1993-04-28 Ciba-Geigy Ag Acetylen-Verbindungen, verwendbar als Leukotrien-Antagonisten
SE9103397D0 (sv) 1991-11-18 1991-11-18 Kabi Pharmacia Ab Nya substituerade salicylsyror
IL105558A (en) 1992-05-18 1998-04-05 Zeneca Ltd Tertiary carbinols with channel activity potassium process for their preparation and pharmaceutical preparations containing them
GB9305295D0 (en) * 1993-03-15 1993-05-05 Zeneca Ltd Therapeutic compounds
GB9309716D0 (en) 1993-05-12 1993-06-23 Zeneca Ltd Heterocyclic derivatives
GB9310069D0 (en) 1993-05-17 1993-06-30 Zeneca Ltd Heterocyclic compounds
GB9310095D0 (en) 1993-05-17 1993-06-30 Zeneca Ltd Therapeutic compounds
GB2278054A (en) * 1993-05-18 1994-11-23 Zeneca Ltd Compounds for the treatment of urinary incontinence
GB9505082D0 (en) 1995-03-14 1995-05-03 Zeneca Ltd Medicament
GB9607458D0 (en) 1996-04-10 1996-06-12 Zeneca Ltd Enzymatic process for stereoselective preparation of therapeutic amides
GB9804648D0 (en) * 1998-03-06 1998-04-29 Zeneca Ltd Chemical compounds
GB9805520D0 (en) 1998-03-17 1998-05-13 Zeneca Ltd Chemical compounds
GB9811427D0 (en) * 1998-05-29 1998-07-22 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
KR20020067498A (ko) 2002-08-22
MY127036A (en) 2006-11-30
RU2255085C2 (ru) 2005-06-27
HUP0202725A2 (hu) 2003-01-28
WO2001017956A1 (en) 2001-03-15
DE60009319D1 (de) 2004-04-29
EP1214296B1 (en) 2004-03-24
CO5190690A1 (es) 2002-08-29
JP2003508515A (ja) 2003-03-04
AU760061B2 (en) 2003-05-08
EE05080B1 (et) 2008-10-15
KR100692232B1 (ko) 2007-03-09
RU2002108508A (ru) 2004-01-20
TW577867B (en) 2004-03-01
CN1387509A (zh) 2002-12-25
BG106520A (en) 2003-03-31
ES2216940T3 (es) 2004-11-01
AU6854300A (en) 2001-04-10
SK3002002A3 (en) 2002-07-02
TR200200550T2 (tr) 2002-06-21
AR035163A1 (es) 2004-05-05
HUP0202725A3 (en) 2005-04-28
ATE262507T1 (de) 2004-04-15
CZ2002773A3 (cs) 2002-06-12
NO20021040L (no) 2002-05-02
DK1214296T3 (da) 2004-07-05
EP1214296A1 (en) 2002-06-19
US6689909B1 (en) 2004-02-10
IL148111A0 (en) 2002-09-12
NZ517147A (en) 2003-11-28
IS6285A (is) 2002-02-26
IL148111A (en) 2007-05-15
IS2069B (is) 2005-11-15
BR0013694A (pt) 2002-05-21
HK1045496B (zh) 2004-10-21
HK1045496A1 (en) 2002-11-29
DE60009319T2 (de) 2005-03-31
PT1214296E (pt) 2004-08-31
BG65099B1 (bg) 2007-02-28
MXPA02002319A (es) 2002-07-30
CA2381581A1 (en) 2001-03-15
CN1235877C (zh) 2006-01-11
NO20021040D0 (no) 2002-03-01
PL353887A1 (en) 2003-12-15
SK286774B6 (sk) 2009-05-07

Similar Documents

Publication Publication Date Title
LU93311I2 (fr) Mancozèbe, valifenalate
DE60019577D1 (de) 4, 5, 6, 7-tetrahydroindazolderivate als antitumormittel
DZ3168A1 (fr) Dérivés de purine.
TR200000520A3 (tr) 4-Fenil-piridin türevleri.
IS5860A (is) 4,4-bíarýlpíperidín afleiður með ópíóíð viðtaka virkni
ATE435861T1 (de) 12,13-cyclopropan-epothilonderivate
NO20002217D0 (no) Cyclopentan-heptansyre, 2-heteroarylalkenylderivater som terapeutiske midler
DZ2569A1 (fr) Dérivés 1,2,3,4-tétrahydronaphtalène substitués.
ATE315036T1 (de) 2,4-diaminopyrimidinderivate als immunosuppressiva
EE200200113A (et) Püruvaatdehüdrogenaasi aktiivsust tõstvad asendatud N-fenüül-2-hüdroksü-2-metüül-3,3,3-trifluoropropaanamiidi derivaadid
NO20003825L (no) 1,3,4 - oxadiazolonderivater
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
DE60000826D1 (de) 14.beta.,17-alpha-hydroxymethylandrostan derivate als androgene
IL160455A0 (en) Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity
SI1214296T1 (en) Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity
ES1043697Y (es) Contenedor-expositor perfeccionado.
ES1044451Y (es) Gavion perfeccionado.
ES1043296Y (es) Mosquero perfeccionado.
ES1043014Y (es) Rodillo perfeccionado.
ES1038878Y (es) Farola perfeccionada.
ES1044266Y (es) Carta-sobre perfeccionada.
ES1044625Y (es) Garrafa perfeccionada.
ES1041942Y (es) Piñata perfeccionada.
ES1044754Y (es) Acietera perfeccionada.
ES1043769Y (es) Toalla perfeccionada.

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20090830